111 related articles for article (PubMed ID: 10422817)
1. Immunohistochemical expression of p53 and bcl-2 proteins is not associated with sarcomatoid change in renal cell carcinoma.
Kanamaru H; Li B; Miwa Y; Akino H; Okada K
Urol Res; 1999 Jun; 27(3):169-73. PubMed ID: 10422817
[TBL] [Abstract][Full Text] [Related]
2. Distinct immunophenotypes and prognostic factors in renal cell carcinoma with sarcomatoid differentiation: a systematic study of 19 immunohistochemical markers in 42 cases.
Yu W; Wang Y; Jiang Y; Zhang W; Li Y
BMC Cancer; 2017 Apr; 17(1):293. PubMed ID: 28449664
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical study of bcl-2, p53 and Ki-67 expressions in collecting duct carcinoma of the kidney. Five cases and review of the literature on bcl-2, p53 and Ki-67 expressions in renal cell carcinoma and transitional cell carcinoma.
Suzuki K; Tokue A
Urol Int; 2002; 69(1):57-62. PubMed ID: 12119441
[TBL] [Abstract][Full Text] [Related]
4. Expression of bcl-2, p53 oncoprotein, and proliferating cell nuclear antigen in renal cell carcinoma.
Sejima T; Miyagawa I
Eur Urol; 1999; 35(3):242-8. PubMed ID: 10072628
[TBL] [Abstract][Full Text] [Related]
5. The relationship of expression of bcl-2, p53, and proliferating cell nuclear antigen (PCNA) to cell proliferation and apoptosis in renal cell carcinoma.
Zhu Z; Xing S; Cheng P; Li G; Yang Y; Zeng F; Lu G
J Huazhong Univ Sci Technolog Med Sci; 2004; 24(4):354-7. PubMed ID: 15587397
[TBL] [Abstract][Full Text] [Related]
6. Expression of p53 and bcl-2 in primary locally confined renal cell carcinomas: no evidence for prognostic significance.
Hofmockel G; Wittmann A; Dammrich J; Bassukas ID
Anticancer Res; 1996; 16(6B):3807-11. PubMed ID: 9042262
[TBL] [Abstract][Full Text] [Related]
7. Expression of hypoxia inducible factor-1α and 2α in conventional renal cell carcinoma with or without sarcomatoid differentiation.
Ku JH; Park YH; Myung JK; Moon KC; Kwak C; Kim HH
Urol Oncol; 2011; 29(6):731-7. PubMed ID: 19914104
[TBL] [Abstract][Full Text] [Related]
8. Expression of AEG-1 and p53 and their clinicopathological significance in malignant lesions of renal cell carcinomas: a microarray study.
Erdem H; Oktay M; Yildirim U; Uzunlar AK; Kayikci MA
Pol J Pathol; 2013 Apr; 64(1):28-32. PubMed ID: 23625597
[TBL] [Abstract][Full Text] [Related]
9. Cell proliferative activity and expression of cell-cell adhesion factors (E-cadherin, alpha-, beta-, and gamma-catenin, and p120) in sarcomatoid renal cell carcinoma.
Kuroiwa K; Konomoto T; Kumazawa J; Naito S; Tsuneyoshi M
J Surg Oncol; 2001 Jun; 77(2):123-31. PubMed ID: 11398166
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathological features and prognosis of renal cell carcinoma with sarcomatoid differentiation].
Jiang Y; Su G; Yu W; Li J; Lu Q; Li Y; Zhang W
Zhonghua Zhong Liu Za Zhi; 2015 Nov; 37(11):823-6. PubMed ID: 26887511
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma.
Phuoc NB; Ehara H; Gotoh T; Nakano M; Yokoi S; Deguchi T; Hirose Y
Urology; 2007 May; 69(5):843-8. PubMed ID: 17482919
[TBL] [Abstract][Full Text] [Related]
12. p53 protein expression but not mdm-2 protein expression is associated with rapid tumor cell proliferation and prognosis in renal cell carcinoma.
Moch H; Sauter G; Gasser TC; Buchholz N; Bubendorf L; Richter J; Jiang F; Dellas A; Mihatsch MJ
Urol Res; 1997; 25 Suppl 1():S25-30. PubMed ID: 9079753
[TBL] [Abstract][Full Text] [Related]
13. p53 and Ki-67 expression in renal cell carcinomas of pregnant women and their correlation with prognosis: a pilot study.
Pomara G; Salinitri G; Nesi G; Maio E; Minervini A; Gammazza AM; Francesca F; Cappello F; Selli C
Int J Gynecol Cancer; 2008; 18(1):132-5. PubMed ID: 18070050
[TBL] [Abstract][Full Text] [Related]
14. Adult renal cell carcinoma with rhabdoid differentiation: incidence and clinicopathologic features in Chinese patients.
Yang X; Xi C; Jin J; Zhou L; Su J; Liu L; Liu Y
Ann Diagn Pathol; 2015 Apr; 19(2):57-63. PubMed ID: 25708024
[TBL] [Abstract][Full Text] [Related]
15. Frequent expression of Bcl-2 in renal-cell carcinomas carrying wild-type p53.
Tomita Y; Bilim V; Kawasaki T; Takahashi K; Okan I; Magnusson KP; Wiman KG
Int J Cancer; 1996 May; 66(3):322-5. PubMed ID: 8621251
[TBL] [Abstract][Full Text] [Related]
16. Frequent loss of expression of the pro-apoptotic protein Bim in renal cell carcinoma: evidence for contribution to apoptosis resistance.
Zantl N; Weirich G; Zall H; Seiffert BM; Fischer SF; Kirschnek S; Hartmann C; Fritsch RM; Gillissen B; Daniel PT; Häcker G
Oncogene; 2007 Oct; 26(49):7038-48. PubMed ID: 17486061
[TBL] [Abstract][Full Text] [Related]
17. Nuclear DNA content-derived parameters correlated with heterogeneous expression of p53 and bcl-2 proteins in clear cell renal carcinomas.
Pepe S; Ruggiero A; D'Acquisto M; De Laurentiis M; De Placido S; Sandomenico C; Staibano S; De Rosa G; Lucariello A; D'Armiento M; Bianco AR
Cancer; 2000 Sep; 89(5):1065-75. PubMed ID: 10964337
[TBL] [Abstract][Full Text] [Related]
18. Adult renal cell carcinoma with rhabdoid morphology represents a neoplastic dedifferentiation analogous to sarcomatoid carcinoma.
Chapman-Fredricks JR; Herrera L; Bracho J; Gomez-Fernandez C; Leveillee R; Rey L; Jorda M
Ann Diagn Pathol; 2011 Oct; 15(5):333-7. PubMed ID: 21665507
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates.
Nakopoulou L; Vourlakou C; Zervas A; Tzonou A; Gakiopoulou H; Dimopoulos MA
Hum Pathol; 1998 Feb; 29(2):146-54. PubMed ID: 9490274
[TBL] [Abstract][Full Text] [Related]
20. Mutant p53 expression in kidney tubules adjacent to renal cell carcinoma: evidence of a precursor lesion.
Lai R; el Dabbagh L; Mourad WA
Mod Pathol; 1996 Jun; 9(6):690-5. PubMed ID: 8782209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
